For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
search
Documents
Optimization of Mobile Phase Composition for the Analysis of Synthetic Oligonucleotides using a Clarity Oligo-XT Column (TN-1200)
Mobile phase composition for the analysis of three different synthetic oligonucleotides models (Bridged Nucleic Acid, Antisense RNA, and DNA phosphorothioate) was studied and optimized using a Clarity 2.6 μm Oligo-XT C18 column.

Optimization of Mobile Phase Composition for the Analysis of Synthetic Oligonucleotides using a Clarity Oligo-XT Column (TN-1200)

Mobile phase composition for the analysis of three different synthetic oligonucleotides models (Bridged Nucleic Acid, Antisense RNA, and DNA phosphorothioate) was studied and optimized using a Clarity 2.6 μm Oligo-XT C18 column.
Document Type:
Technical Notes
Target Industries:
Biopharmaceutical Analysis, Pharmaceutical
Techniques:
HPLC, HPLC Reversed Phase, Oligonucleotide Analysis
Brands:
Clarity HPLC Columns
Separation Modes:
Reversed Phase
Phases:
Clarity Oligo-XT
save_alt Download
favorite_border
Phenomenex logo
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US

PRODUCTS AND SERVICES

Products

Techniques

Industries

Quick Order

SUPPORT 

Product/Method Support

Product Troubleshooting

Contact Us

CQA / CofA


OUR COMPANY

About Phenomenex

News

Blog

Danaher Life Sciences


Terms and Conditions Privacy Statement Quality Policy Terms of Use Trademarks CA Supply Chains Act CA Consumer Privacy Act Cookie Policy Impressum © 2024 Phenomenex, Inc. All rights reserved.